{"disease":{"id":"lipid-metabolism-inborn-errors","name":"lipid metabolism inborn errors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05425745","title":"Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"NewAmsterdam Pharma","has_results":true},{"nct_id":"NCT00092820","title":"Sitosterolemia Extension Study (0653-004)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT00092807","title":"Sitosterolemia Extension Study (0653-003)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT01963650","title":"Natural History Study of Children With Metachromatic Leukodystrophy","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Shire","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}